3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Young TIL: new trials by email Literature Review of Young TIL trials Research Report on Young TIL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma Aldesleukin, Fludarabine, Cyclophosphamide - Metastatic Melanoma | Phase 2 | Completed | National Cancer Institute (NCI) | 33 | 2013-12-12 | 2023-01-18 |
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers Fludarabine, Cyclophosphamide, Young TIL - Cervical Cancer, Oropharyngeal Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 29 | 2012-04-13 | 2018-03-07 |
| Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI... Aldesleukin, Cyclophosphamide, Fludarabine - Metastatic Melanoma, Skin Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 102 | 2011-03-24 | 2025-12-19 |
Melanoma (2) · Anus Neoplasms (1) · Oropharyngeal Neoplasms (1) · Papillomavirus Infections (1) · Penile Neoplasms (1) · Skin Neoplasms (1) · Uterine Cervical Neoplasms (1) · Vaginal Neoplasms (1)
National Cancer Institute (NCI) (3)
United States (3)
Steven A Rosenberg, M.D. (2) · Stephanie L Goff, M.D. (1)